Computational Drug Repurposing Approach to Identify Novel Inhibitors of ILK Protein for Treatment of Esophageal Squamous Cell Carcinoma

Figure 4

Sensorgram plots for the compounds selected by virtual screening and computational docking ((b) nilotinib; (c) teniposide) and of ILK-IN-3 (a) as the control.

(a)

(b)

(c)